We are live on ! Find out more
GCM

Galibier Capital Management Portfolio holdings

AUM $300M
1-Year Est. Return 22.03%
This Fund
S&P 500
This Quarter Est. Return
+0.88%
1 Year Est. Return
+22.03%
3 Year Est. Return
+66.83%
5 Year Est. Return
+107.72%
10 Year Est. Return
–
AUM
$251M
AUM Growth
+$31.7M
Cap. Flow
+$28M
Cap. Flow %
11.12%
Top 10 Hldgs %
80.74%
Holding
32
New
1
Increased
15
Reduced
5
Closed
1

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$13M
2
NTR icon
Nutrien
NTR
+$7.8M
3
ENB icon
Enbridge
ENB
+$5.27M
4
MFC icon
Manulife Financial
MFC
+$4.84M
5
CM icon
Canadian Imperial Bank of Commerce
CM
+$3.04M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$10.8M
2
AIG icon
American International
AIG
+$1.71M
3
WBA
Walgreens Boots Alliance
WBA
+$1.08M
4
BUD icon
AB InBev
BUD
+$819K
5
PHG icon
Philips
PHG
+$407K

Sector Composition

Rank Sector Weight
1 Financials 33.46%
2 Energy 16.58%
3 Healthcare 13.88%
4 Industrials 13.78%
5 Materials 12.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CM icon
1
Canadian Imperial Bank of Commerce
CM
$107B
$32.9M 13.1%
797,718
+77,434
+11% +$3.04M
MFC icon
2
Manulife Financial
MFC
$72.6B
$32M 12.75%
1,745,816
+273,952
+19% +$4.84M
NTR icon
3
Nutrien
NTR
$32.7B
$30.3M 12.04%
607,201
+152,810
+34% +$7.8M
CVE icon
4
Cenovus Energy
CVE
$54.6B
$22.4M 8.93%
2,389,397
+12,403
+0.5% +$113K
ENB icon
5
Enbridge
ENB
$124B
$19.2M 7.65%
547,466
+152,431
+39% +$5.27M
EMR icon
6
Emerson Electric
EMR
$82.9B
$15.7M 6.25%
234,872
+30,500
+15% +$1.92M
ABBV icon
7
AbbVie
ABBV
$458B
$14.4M 5.73%
+190,182
New +$13M
GIB icon
8
CGI
GIB
$13.9B
$14.1M 5.59%
177,686
+33,004
+23% +$2.57M
BNS icon
9
Scotiabank
BNS
$106B
$11.2M 4.46%
197,081
+41,078
+26% +$2.21M
WBA
10
DELISTED
Walgreens Boots Alliance
WBA
$10.7M 4.24%
192,712
-20,172
-9% -$1.08M
OSK icon
11
Oshkosh
OSK
$9.67B
$5.72M 2.28%
75,460
+5,940
+9% +$455K
SRCL
12
DELISTED
Stericycle Inc
SRCL
$4M 1.59%
78,596
+5,000
+7% +$233K
HSIC icon
13
Henry Schein
HSIC
$9.74B
$3.46M 1.38%
54,556
– –
MIDD icon
14
Middleby
MIDD
$6.05B
$3.22M 1.28%
27,514
+2,605
+10% +$320K
STN icon
15
Stantec
STN
$7.69B
$3.19M 1.27%
144,108
– –
RYAAY icon
16
Ryanair
RYAAY
$29.5B
$2.79M 1.11%
105,268
+18,448
+21% +$457K
AZN icon
17
AstraZeneca
AZN
$263B
$2.55M 1.01%
28,580
+5,692
+25% +$494K
JPM icon
18
JPMorgan Chase
JPM
$939B
$2.23M 0.89%
18,949
– –
BKNG icon
19
Booking.com
BKNG
$138B
$2.18M 0.87%
27,800
– –
ING icon
20
ING
ING
$93.8B
$2.04M 0.81%
195,227
+7,725
+4% +$81.3K
GOOG icon
21
Alphabet (Google) Class C
GOOG
$3.9T
$1.98M 0.79%
32,520
-4,400
-12% -$260K
CTSH icon
22
Cognizant
CTSH
$21.5B
$1.94M 0.77%
32,219
– –
TFC icon
23
Truist Financial
TFC
$63.2B
$1.9M 0.76%
35,593
– –
PHG icon
24
Philips
PHG
$25.4B
$1.85M 0.74%
50,482
-11,071
-18% -$407K
BUD icon
25
AB InBev
BUD
$158B
$1.8M 0.72%
18,883
-8,633
-31% -$819K
1
2

Similar funds

LIG
Lokken Investment Group Lewes, Delaware $291M AUM 13.61% 1-Year Est. Return
LSA
Lion Street Advisors Austin, Texas $289M AUM 3.13% 1-Year Est. Return
OPPS
Obsidian Personal Planning Solutions Rockville, Maryland $288M AUM 10% 1-Year Est. Return
FIBT
First International Bank & Trust Watford City, North Dakota $288M AUM 6.85% 1-Year Est. Return
SFG
Sterling Financial Group Pasadena, California $316M AUM 10.54% 1-Year Est. Return
FW
FullCircle Wealth Dallas, Texas $284M AUM 15.13% 1-Year Est. Return
SC
Solari Capital Palm Beach Gardens, Florida $318M AUM
AFWM
Abich Financial Wealth Management Ashburn, Virginia $281M AUM

Galibier Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Galibier Capital Management held 32 positions worth $251M, up 14% from $220M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Galibier Capital Management deployed $28M of net new capital in Q3 2019, opening 1 new position and adding to 15 existing holdings. Its largest new stake was AbbVie: 190,182 shares worth $14.4M.

By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 33% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was Medtronic, an estimated $10.8M trimmed.

  • Galibier Capital Management's largest Q3 2019 buy was AbbVie: 190,182 shares worth $14.4M.
  • Galibier Capital Management added most to Nutrien in Q3 2019, an estimated $7.8M increase.
  • Galibier Capital Management's biggest Q3 2019 reduction was Medtronic, cutting an estimated $10.8M.
  • Galibier Capital Management fully exited American International in Q3 2019, selling an estimated $1.71M.
  • Galibier Capital Management's ten largest holdings make up 81% of its $251M portfolio in Q3 2019.
  • Galibier Capital Management opened 1 new position and closed 1 in Q3 2019.
  • Galibier Capital Management's portfolio value rose 14% quarter-over-quarter to $251M.

Based on Galibier Capital Management's 13F filing for Q3 2019, filed 8 Nov 2019.